If there is no intended clinical benefit to the participant, what must be communicated?

• A. There is no intended clinical benefit.
• B. There is an intended clinical benefit.
• C. The trial provides direct medical care.
• D. Compensation will be provided only if benefits occur.

Answer: (A)

The main idea is how informed consent handles expectations about personal benefit. When a study does not aim to provide direct medical benefit to the participant, the consent document should clearly state that there is no intended clinical benefit for the individual. This explicit statement helps ensure you understand that you’re agreeing to contribute to research, not to receive a personal health advantage from the trial.

Saying there is no intended clinical benefit communicates a truthful boundary between research and routine care, reducing the risk of false hopes and aligning with ethical standards that require transparent disclosure of what participants can expect. It also keeps open the possibility that valuable knowledge or benefits to others may come from the study, even if you won’t personally gain a medical advantage.

Why the other options don’t fit: claiming there is an intended clinical benefit would be misleading if the study isn’t designed to provide one; asserting the trial provides direct medical care suggests you will receive personal health benefits or standard treatment which isn’t guaranteed in research contexts; and stating compensation is conditional on benefits could create misunderstandings about the purpose of the trial and raise ethical concerns about inducement.